Replies to post #160112 on Biotech Values

[DewDiligence]

More on ABT’s prospects in emerging markets:

http://www.forbes.com/sites/brucejapsen/2013/04/17/new-abbott-fills-chinas-craving-for-baby-formula-nutrition

[DewDiligence]

ABT +3.4% on upgrade from Goldman Sachs that has nothing really new to say. The stock is +21% during 2013 (adjusting for the separation of ABBV on 1/2/13).

p.s. I have a 25% ABT weighting in the SI charity contest own a lot of shares in my real portfolio.